REQUEST A DEMO
Total
USD $0.00
Search more companies

Emami Biotech (Singapore) Pte. Ltd. (Singapore)

Main Activities: General Line Grocery Merchant Wholesalers
Secondary Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Emami Biotech (Singapore) Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Primary Business Activity: wholesale of palm oil (trade in forex derivatives options margin trade futures agro commodities); Secondary Business Activity: research and experimental development on natural sciences n.e.c.

Headquarters
100 Peck Seah Street, #07-08 Ps100, Singapore
Singapore; Singapore; Postal Code: 079333

Contact Details: Purchase the Emami Biotech (Singapore) Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Emami Biotech (Singapore) Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Emami Biotech (Singapore) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Emami Biotech (Singapore) Pte. Ltd. report to view the information.
Incorporation Date:
January 08, 2009
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
97.81%
Company Performance
Financial values in the chart are available after Emami Biotech (Singapore) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-53.89%
Total operating revenue
-53.89%
Net Profit (Loss) for the Period
-97.98%
Total assets
157.96%
Total equity
0.42%
Net Profit Margin
-4.23%
Return on Equity (ROE)
20.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?